According to the strategy of 2022-2030, Armenia has adopted a policy aimed at eliminating hepatitis, informed the Ministry of Health. The goal is to drastically reduce the number of cases of this illness in the country by 2030—by integrating patient care and treatment services.

Since 2020, direct-acting antiviral drugs are provided free of charge to patients in Armenia with chronic hepatitis C. In order to ensure the continuity of the program, the procedure for treating patients with hepatitis C with new drugs was recently approved.

A total of 517 patients in Armenia have received treatment against hepatitis C so far this year.

Since 1999, vaccinations against hepatitis B have been carried out in Armenia, thanks to which there are no cases of acute hepatitis B among children up to 14 years old in the country.

Also, public events, free, anonymous examinations are held on a regular basis in the capital Yerevan and Armenia’s provinces for the purpose of early detection of hepatitis.